Baader Bank Aktiengesellschaft’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,600	Closed	-$634K	–	420
2024 Q1	$634K	Buy	+4,600	New	+$634K	0.05%	191
2023 Q1	–	Sell	-1,700	Closed	-$203K	–	362
2022 Q4	$203K	Buy	+1,700	New	+$203K	0.01%	243